INTRODUCTION Rationale for cardiac rehabilitation
The mortality in terms of premature death from coronary artery disease (CAD) in Northern Ireland accounted for 255 deaths in the 15-74 age group per 100,000 population in 1993.1 These figures suggest that death from CAD in Northern Ireland is still among the highest in the world, even though the rate has been declining in recent years. The increasing number ofpatients surviving cardiac events may be attributable to primary prevention strategies, recent improvements in the management of acute myocardial infarction (MI) patients, and the increased number of successful revascularisation procedures (coronary artery bypass grafts and angioplasties) performed each year.2 However, such successful outcomes are responsible for the continuing financial burden to the Health and Personal Social Services, and although direct costings are not available for Northern Ireland it has been suggested that direct treatment of CAD costs £30 million in Ireland annually, with £100 million lost as an indirect result of the disease each year.3 Even the most successful medical treatment or revascularisation procedure does not counteract the cumulative effect of inactivity, the traumatic effect of the operation, nor does it ensure the adoption of a healthier and more active lifestyle.4'5 Signs and symptoms may return in many patients, and it is suggested that up to 20% of venous coronary bypass grafts may be occluded within the first year, rising to 50% after 10 years. 6 The rate of restenosis in those treated by Percutaneous Transluminal Coronary Angioplasty (PTA) is similarly high, since as many as 30% of vessels may restenose within the first 6 months.7 A cardiac rehabilitation programme aimed at maximising patients' quality of life and reducing signs and symptoms associated with CAD is, therefore, an essential component ofthe secondary prevention of coronary disease. There is also increasing evidence that cardiac rehabilitation may maximise the potential health gains in a wider population of patients, such as those with heart failure, valve surgery, angina, hypertension and after the correction ofcongenital heart lesions; however many of these patients are currently excluded from cardiac rehabilitation programmes. It has been suggested that for a population of 200 Cardiac rehabilitation has been traditionally described in terms of four discrete phases or stages, although there is still some discrepancy in the literature as to the duration of these phases and how they are utilised in the rehabilitation process. Phase I covers the period of hospital stay, phase II is the period following hospital discharge and can last from two up to twelve weeks, phase III is the period when most gym sessions begin, and phase IV is the period when patients receive less supervision, and may begin six months after the cardiac event.
BENEFITS OF CARDIAC REHABILITATION
Exercise based cardiac rehabilitation may reduce mortality and morbidity by as much as 25%.1o
However, the efficacy of rehabilitation extends far beyond such end points and significant improvements in quality of life in terms ofphysical well-being, psychological well being, decreased hospitalisation, and ability to return to work are well documented. More specifically, the benefits ofthe exercise component ofcardiac rehabilitation occur via the following mechanisms: increasing ischaemic threshold, improving left ventricular function, increased coronary circulation, improving lipid profiles, decreasing serum catecholamines, lowering blood pressure, decreasing platelet aggregation and stimulating fibrinolysis, improving psychological status, and reducing skeletal muscle wasting".1' As not all exercise will result in the above purported improvements, it is thought that the key to optimising these outcomes lies within the exercise dose. It is somewhat surprising then that the concept of exercise dose has gained only lukewarm interest in the field of cardiac research, and as no standard protocol for exercise prescription exists in Northern Ireland it is likely that these services will vary considerably at local, district and regional level. The aims of our survey were therefore to establish the extent of the provision of phase III, exercise-based cardiac rehabilitation in Northern Ireland, and to identify the components of these schemes. Specific objectives were employed to identify the characteristics of patients referred to cardiac rehabilitation schemes; to identify the indices used to ascertain the health status of individuals on entry to, and discharge from cardiac rehabilitation schemes; to identify the exercise dose currently used in cardiac rehabilitation schemes; to identify the outcome measures currently used to assess health gain following cardiac rehabilitation; and to ascertain the facilities available for the provision of phase IV of cardiac rehabilitation.
METHODS
Survey research techniques were used in the present study. To identify centres offering cardiac rehabilitation, each of the four health boards in Northern Ireland was initially contacted. As none of the health boards could provide the information sought, the Northern Ireland Chest Heart and Stroke Association was contacted, and subsequently a comprehensive list of hospital and health centre-based cardiac rehabilitation, and independent self-help cardiac groups, was obtained. At this point each of the services was contacted to determine whether or not their service constituted Phase III of cardiac rehabilitation. A total ofeight hospital-based, and one health centrebased, cardiac rehabilitation programmes were identified as offering a phase III service. A postal questionnaire was then sent to the co-ordinators of each programme, which sought information pertaining to the extent of the current provision and the components of each programme. Specifically, this data included entry criteria, details of assessment of health status, details of exercise dosage and the outcome measures currently used.
RESULTS
Eight of the nine identified centres returned a completed questionnaire. All eight centres offered rehabilitation to MI patients, seven centres included coronary artery bypass graft (CABG) patients, but only one programme accepted valvular disease, heart failure, angina, PTCA and stent patients. Most programmes have adopted exclusion criteria to ensure that high risk patients are not included in their moderate intensity exercise based rehabilitation programmes. Those exclusion criteria common to all centres included uncontrolled arrythmias, acute illness, active pericarditis, with a majority of centres (n=6) also listing severe aortic stenosis, tachycardia (> 1 20 bpm), uncontrolled hypertension, valvular disease and ischaemic signs occurring early on exercise test as exclusion criteria.
While cardiologists were largely responsible for the referral of patients to cardiac rehabilitation programmes, a diversity of professions including general practitioners, physiotherapists, nurses, and surgeons were also identified as being involved in the referral process.
The use of exercise testing as a measure of functional capacity and assessment of health status was by no means the norm in our study. In only one out ofthe seven programmes involving CABG patients was preadmission graded exercise testing (GXT) a requirement, with a further four centres reporting that GXT's were "sometimes" performed and the remaining two stating that they were never carried out. Routine preadmission GXT is standard practice for MI patients in only three of the programmes, performed sometimes in four of the programmes, and never performed in the one remaining programme. Furthermore, in four centres where GXT's are conducted, the respondents stated that they did not in fact receive the results of the tests.
Those programmes which did obtain the results of the GXT's incorporate these values along with scores from the Borg scale of perceived exertion12 to determine and subsequently monitor appropriate exercise intensities. Most centres prescibed exercise intensity levels of 60-70% of determined maximal heart rate and/or Borg ratings ofbetween I 1-15. 12 It is assumed that those centres with no objective measure of functional capacity depend on an age-related equation to determine exercise intensity level, which is further used along with a Borg scale to monitor subsequent gains in functional capacity. All the programmes recognised the importance of exercise progression. When the patient failed to reach a Borg rating of 11 and/or when they were not achieving their target heart rate during their routine exercise, the level was increased. However, the manner in which the exercise demands were increased varied between programmes. Some programmes considered it to be initially safer to progress the exercise by increasing the frequency or the duration of the exercise, rather than its intensity. Others also concomitantly increased the intensity. All patients irrespective of geographical location or clinical presentation were offered cardiac rehabilitation once a week, but were also advised to take part in an additional home exercise programme several times per week. The duration of the third phase of cardiac rehabilitation varied from three up to thirteen weeks in the eight centres. The most common duration was six weeks (n=4), followed by eight weeks (n=2), with one programme of three weeks and the remaining centre offering a thirteen-week programme. These findings reflect a general trend in Northern Ireland towards the provision of a short course of physical training, with "advice to continue exercising after discharge". While most programmes did not rely solely on referral forms for baseline measures, not all programmes obtained a baseline measure of functional capacity, and only one programme obtained a baseline measure of cholesterol. Furthermore, only two of the programmes measured whether there was a programmemediated improvement in functional capacity, as measured by GXT (one treadmill and one cycle ergometer), three did not attempt to measure outcomes, and one centre relied on perceived satisfaction on the part of the patients. However, none of the centres reported the use of quality of guidelines"8 which suggest intensities between 60-70% heart rate max are adequate to attain health related benefits such as decreased angina, '9 decreased hospitalisation,20 and increased vital capacity,20 while others have argued that in previously sedentary persons even lower will result in health related benefits.2' Without a formal exercise test, or the use of some other valid and reliable functional capacity measure, it is difficult to prescribe an exercise programme suited to the individual needs of the patient. It has been suggested that GXT and risk factor assessment are necessary to classify patients into low, intermediate, or high risk categories and to individualise exercise programmes accordingly.22 This highlights the importance of GXT in patient categorisation which will be a major determinant in the design of the patient's programme with regard to the type, frequency, intensity, and duration of training. At present cardiac rehabilitation is currently based on the provision of moderate intensity exercise programmes. This survey has therefore identified the need for development of additional programmes, designed to take into account the needs and limitations of special cardiac patient populations. More scientific data regarding the optimum exercise intensity for the different groups of patients is needed if a comprehensive service is to be offered to this ever-increasing section of the population. Findings from this survey highlight the need to find an alternative, userfriendly measure of functional capacity that is sensitive, but which still correlates strongly with the GXT. It has been recommended that programmes should be of at least 12 weeks' duration, based on the suggestion that training effects increase in an S shaped curve plateauing at thirteen/fourteen weeks.23 In view of the more conservative approach to exercise in the cardiac patient, and the fact that individuals do not adapt to lifestyle changes in the same way, or at the same pace, a much longer time span may be needed to obtain optimal health related benefits. Despite the acclaimed additional benefits of longer programmes, it would seem that the duration of cardiac rehabilitation programmes is determined by financial limitations rather than sound scientific research. If the current programmes are of insufficient duration to bring about noticeable improvements in the patient's functional status, it is unlikely that the patient will be led to continue with the prescribed regime of exercise or adopt a healthier lifestyle. Conversely, it is not the aim to offer cardiac rehabilitation for an indefinite period, but rather through rehabilitation and education to enable the patient to achieve optimal functional status in an independent manner. Thus there is an urgent requirement to determine the optimum programme length and to subsequently implement such findings into good practice. One of the main criticisms of hospital based cardiac rehabilitation programmes in Northern Ireland is their limited duration which brings any controlled benefit to an abrupt end. Self help/support groups could constitute phase IV of cardiac rehabilitation and act as an invaluable step-down mechanism from hospital based cardiac rehabilitation, by providing the reinforcement considered necessary for long term compliance to a healthier and more active lifestyle. Nevertheless 
